Innocan Pharma Stock Forecast

Sell candidate since Jul 27, 2026 Loss -25.42%

The Innocan Pharma Corporation stock price fell by -12.00% on the last day (Monday, 10th Aug 2026) from $2.50 to $2.20. During the last trading day the stock fluctuated 13.64% from a day low at $2.20 to a day high of $2.50. The price has risen in 5 of the last 10 days but is still down by -18.52% for this period. Volume has increased on the last day by 3 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 thousand shares were bought and sold for approximately $7.48 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.99% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.73 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

INNO.CN Signals & Forecast

There are few to no technical positive signals at the moment. The Innocan Pharma Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.52 and $2.94. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 15, 2026, and so far it has fallen -37.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Innocan Pharma Corporation gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Innocan Pharma Corporation stock

Innocan Pharma Corporation finds support from accumulated volume at $2.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.300 between high and low, or 13.64%. For the last week, the stock has had daily average volatility of 7.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INNO.CN) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Innocan Pharma Corporation to open at $2.30, and during the day (based on 14 day Average True Range), to move between $2.08 and $2.32, which gives a possible trading interval of +/-$0.237 (+/-11.40%) up or down from last closing price. If Innocan Pharma Corporation takes out the full calculated possible swing range there will be an estimated 11.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.18 (0.91%) than the resistance at $2.50 (13.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Innocan Pharma Corporation stock A Buy?

Innocan Pharma Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.220 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $2.30 ( 4.55%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk